nodes	percent_of_prediction	percent_of_DWPC	metapath
Salicylic acid—PTGS1—malignant glioma	0.532	0.636	CbGaD
Salicylic acid—PTGS2—malignant glioma	0.304	0.364	CbGaD
Salicylic acid—SLC22A8—choroid plexus—malignant glioma	0.0167	0.332	CbGeAlD
Salicylic acid—SLC16A1—retina—malignant glioma	0.00169	0.0336	CbGeAlD
Salicylic acid—PTGS1—endothelium—malignant glioma	0.00156	0.031	CbGeAlD
Salicylic acid—SLC16A1—telencephalon—malignant glioma	0.00155	0.0309	CbGeAlD
Salicylic acid—PTGS2—endothelium—malignant glioma	0.00149	0.0296	CbGeAlD
Salicylic acid—PTGS1—blood vessel—malignant glioma	0.00144	0.0285	CbGeAlD
Salicylic acid—PTGS2—blood vessel—malignant glioma	0.00137	0.0273	CbGeAlD
Salicylic acid—Acetylsalicylic acid—TP53—malignant glioma	0.00135	0.12	CrCbGaD
Salicylic acid—SLCO2B1—telencephalon—malignant glioma	0.00134	0.0266	CbGeAlD
Salicylic acid—SLC16A1—medulla oblongata—malignant glioma	0.00122	0.0243	CbGeAlD
Salicylic acid—SLC16A1—midbrain—malignant glioma	0.00112	0.0222	CbGeAlD
Salicylic acid—SLC16A1—spinal cord—malignant glioma	0.00109	0.0216	CbGeAlD
Salicylic acid—Salicylate-sodium—PTGS1—malignant glioma	0.00106	0.0941	CrCbGaD
Salicylic acid—SLCO2B1—medulla oblongata—malignant glioma	0.00105	0.0209	CbGeAlD
Salicylic acid—SLCO2B1—spinal cord—malignant glioma	0.000936	0.0186	CbGeAlD
Salicylic acid—SLC22A7—brain—malignant glioma	0.000917	0.0182	CbGeAlD
Salicylic acid—SLC22A6—brain—malignant glioma	0.000885	0.0176	CbGeAlD
Salicylic acid—SLC16A1—central nervous system—malignant glioma	0.000883	0.0175	CbGeAlD
Salicylic acid—SLC16A1—cerebellum—malignant glioma	0.000863	0.0172	CbGeAlD
Salicylic acid—ABCB1—blood vessel—malignant glioma	0.000849	0.0169	CbGeAlD
Salicylic acid—PTGS2—embryo—malignant glioma	0.000819	0.0163	CbGeAlD
Salicylic acid—SLCO2B1—central nervous system—malignant glioma	0.000759	0.0151	CbGeAlD
Salicylic acid—SLCO2B1—cerebellum—malignant glioma	0.000742	0.0148	CbGeAlD
Salicylic acid—Magnesium salicylate—PTGS1—malignant glioma	0.000725	0.0645	CrCbGaD
Salicylic acid—Mesalazine—PPARG—malignant glioma	0.000724	0.0644	CrCbGaD
Salicylic acid—Burning sensation—Carmustine—malignant glioma	0.000702	0.0784	CcSEcCtD
Salicylic acid—SLC16A1—brain—malignant glioma	0.000701	0.0139	CbGeAlD
Salicylic acid—PTGS1—telencephalon—malignant glioma	0.000697	0.0138	CbGeAlD
Salicylic acid—Diflunisal—PTGS1—malignant glioma	0.000681	0.0606	CrCbGaD
Salicylic acid—Aminosalicylic Acid—PTGS1—malignant glioma	0.000681	0.0606	CrCbGaD
Salicylic acid—SLC22A8—central nervous system—malignant glioma	0.000667	0.0133	CbGeAlD
Salicylic acid—PTGS2—telencephalon—malignant glioma	0.000666	0.0132	CbGeAlD
Salicylic acid—Salsalate—PTGS1—malignant glioma	0.000616	0.0548	CrCbGaD
Salicylic acid—Meclofenamic acid—PTGS1—malignant glioma	0.000607	0.054	CrCbGaD
Salicylic acid—Salicylate-sodium—PTGS2—malignant glioma	0.000604	0.0538	CrCbGaD
Salicylic acid—SLCO2B1—brain—malignant glioma	0.000603	0.012	CbGeAlD
Salicylic acid—ALB—brain—malignant glioma	0.000552	0.011	CbGeAlD
Salicylic acid—Mesalazine—PTGS1—malignant glioma	0.000535	0.0476	CrCbGaD
Salicylic acid—SLC22A8—brain—malignant glioma	0.00053	0.0105	CbGeAlD
Salicylic acid—PTGS2—medulla oblongata—malignant glioma	0.000523	0.0104	CbGeAlD
Salicylic acid—ABCB1—embryo—malignant glioma	0.000506	0.0101	CbGeAlD
Salicylic acid—Hearing impaired—Temozolomide—malignant glioma	0.000495	0.0553	CcSEcCtD
Salicylic acid—PTGS1—spinal cord—malignant glioma	0.000488	0.0097	CbGeAlD
Salicylic acid—PTGS2—midbrain—malignant glioma	0.000478	0.00951	CbGeAlD
Salicylic acid—Mefenamic acid—PTGS1—malignant glioma	0.000472	0.042	CrCbGaD
Salicylic acid—PTGS2—spinal cord—malignant glioma	0.000467	0.00927	CbGeAlD
Salicylic acid—Skin exfoliation—Carmustine—malignant glioma	0.000466	0.052	CcSEcCtD
Salicylic acid—Acetylsalicylic acid—PTGS1—malignant glioma	0.00046	0.041	CrCbGaD
Salicylic acid—Skin exfoliation—Temozolomide—malignant glioma	0.00045	0.0502	CcSEcCtD
Salicylic acid—ABCB1—retina—malignant glioma	0.000448	0.0089	CbGeAlD
Salicylic acid—Magnesium salicylate—PTGS2—malignant glioma	0.000414	0.0369	CrCbGaD
Salicylic acid—ABCB1—telencephalon—malignant glioma	0.000412	0.00819	CbGeAlD
Salicylic acid—PTGS1—central nervous system—malignant glioma	0.000396	0.00787	CbGeAlD
Salicylic acid—Aminosalicylic Acid—PTGS2—malignant glioma	0.00039	0.0347	CrCbGaD
Salicylic acid—Diflunisal—PTGS2—malignant glioma	0.00039	0.0347	CrCbGaD
Salicylic acid—Deafness—Temozolomide—malignant glioma	0.000383	0.0427	CcSEcCtD
Salicylic acid—PTGS2—central nervous system—malignant glioma	0.000378	0.00752	CbGeAlD
Salicylic acid—PTGS2—cerebellum—malignant glioma	0.00037	0.00735	CbGeAlD
Salicylic acid—Salsalate—PTGS2—malignant glioma	0.000352	0.0313	CrCbGaD
Salicylic acid—Meclofenamic acid—PTGS2—malignant glioma	0.000347	0.0309	CrCbGaD
Salicylic acid—ABCB1—medulla oblongata—malignant glioma	0.000324	0.00643	CbGeAlD
Salicylic acid—PTGS1—brain—malignant glioma	0.000314	0.00625	CbGeAlD
Salicylic acid—Mesalazine—PTGS2—malignant glioma	0.000306	0.0272	CrCbGaD
Salicylic acid—PTGS2—brain—malignant glioma	0.0003	0.00597	CbGeAlD
Salicylic acid—ABCB1—midbrain—malignant glioma	0.000296	0.00588	CbGeAlD
Salicylic acid—ABCB1—spinal cord—malignant glioma	0.000289	0.00574	CbGeAlD
Salicylic acid—Mefenamic acid—PTGS2—malignant glioma	0.00027	0.024	CrCbGaD
Salicylic acid—Weight increased—Temozolomide—malignant glioma	0.000269	0.0301	CcSEcCtD
Salicylic acid—Acetylsalicylic acid—PTGS2—malignant glioma	0.000263	0.0234	CrCbGaD
Salicylic acid—Hallucination—Carmustine—malignant glioma	0.000244	0.0272	CcSEcCtD
Salicylic acid—Hepatitis—Temozolomide—malignant glioma	0.000237	0.0264	CcSEcCtD
Salicylic acid—Hallucination—Temozolomide—malignant glioma	0.000236	0.0263	CcSEcCtD
Salicylic acid—ABCB1—central nervous system—malignant glioma	0.000234	0.00465	CbGeAlD
Salicylic acid—ABCB1—cerebellum—malignant glioma	0.000229	0.00455	CbGeAlD
Salicylic acid—Erythema multiforme—Temozolomide—malignant glioma	0.000224	0.025	CcSEcCtD
Salicylic acid—Tinnitus—Temozolomide—malignant glioma	0.000221	0.0246	CcSEcCtD
Salicylic acid—Erythema—Carmustine—malignant glioma	0.000213	0.0238	CcSEcCtD
Salicylic acid—Erythema—Temozolomide—malignant glioma	0.000206	0.023	CcSEcCtD
Salicylic acid—Dysgeusia—Temozolomide—malignant glioma	0.000202	0.0225	CcSEcCtD
Salicylic acid—ABCB1—brain—malignant glioma	0.000186	0.00369	CbGeAlD
Salicylic acid—Confusional state—Carmustine—malignant glioma	0.000176	0.0196	CcSEcCtD
Salicylic acid—Oedema—Carmustine—malignant glioma	0.000174	0.0194	CcSEcCtD
Salicylic acid—Confusional state—Temozolomide—malignant glioma	0.00017	0.0189	CcSEcCtD
Salicylic acid—Oedema—Temozolomide—malignant glioma	0.000168	0.0188	CcSEcCtD
Salicylic acid—Anorexia—Carmustine—malignant glioma	0.000166	0.0185	CcSEcCtD
Salicylic acid—Anorexia—Temozolomide—malignant glioma	0.00016	0.0179	CcSEcCtD
Salicylic acid—Somnolence—Carmustine—malignant glioma	0.000155	0.0173	CcSEcCtD
Salicylic acid—Decreased appetite—Carmustine—malignant glioma	0.000151	0.0169	CcSEcCtD
Salicylic acid—Somnolence—Temozolomide—malignant glioma	0.00015	0.0167	CcSEcCtD
Salicylic acid—Pain—Carmustine—malignant glioma	0.000149	0.0166	CcSEcCtD
Salicylic acid—Constipation—Carmustine—malignant glioma	0.000149	0.0166	CcSEcCtD
Salicylic acid—Dyspepsia—Temozolomide—malignant glioma	0.000148	0.0165	CcSEcCtD
Salicylic acid—Decreased appetite—Temozolomide—malignant glioma	0.000146	0.0163	CcSEcCtD
Salicylic acid—Pain—Temozolomide—malignant glioma	0.000144	0.0161	CcSEcCtD
Salicylic acid—Constipation—Temozolomide—malignant glioma	0.000144	0.0161	CcSEcCtD
Salicylic acid—Feeling abnormal—Carmustine—malignant glioma	0.000143	0.016	CcSEcCtD
Salicylic acid—Feeling abnormal—Temozolomide—malignant glioma	0.000139	0.0155	CcSEcCtD
Salicylic acid—Urticaria—Temozolomide—malignant glioma	0.000134	0.0149	CcSEcCtD
Salicylic acid—Diarrhoea—Carmustine—malignant glioma	0.000119	0.0133	CcSEcCtD
Salicylic acid—Pruritus—Temozolomide—malignant glioma	0.000119	0.0133	CcSEcCtD
Salicylic acid—Dizziness—Carmustine—malignant glioma	0.000115	0.0128	CcSEcCtD
Salicylic acid—Diarrhoea—Temozolomide—malignant glioma	0.000115	0.0128	CcSEcCtD
Salicylic acid—Dizziness—Temozolomide—malignant glioma	0.000111	0.0124	CcSEcCtD
Salicylic acid—Vomiting—Carmustine—malignant glioma	0.000111	0.0124	CcSEcCtD
Salicylic acid—Rash—Carmustine—malignant glioma	0.00011	0.0123	CcSEcCtD
Salicylic acid—Dermatitis—Carmustine—malignant glioma	0.00011	0.0122	CcSEcCtD
Salicylic acid—Headache—Carmustine—malignant glioma	0.000109	0.0122	CcSEcCtD
Salicylic acid—Vomiting—Temozolomide—malignant glioma	0.000107	0.0119	CcSEcCtD
Salicylic acid—Rash—Temozolomide—malignant glioma	0.000106	0.0118	CcSEcCtD
Salicylic acid—Dermatitis—Temozolomide—malignant glioma	0.000106	0.0118	CcSEcCtD
Salicylic acid—Headache—Temozolomide—malignant glioma	0.000105	0.0118	CcSEcCtD
Salicylic acid—Nausea—Carmustine—malignant glioma	0.000103	0.0115	CcSEcCtD
Salicylic acid—Nausea—Temozolomide—malignant glioma	9.99e-05	0.0112	CcSEcCtD
Salicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	3.08e-05	0.000332	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	3.07e-05	0.000331	CbGpPWpGaD
Salicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	3.01e-05	0.000325	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—malignant glioma	3.01e-05	0.000325	CbGpPWpGaD
Salicylic acid—AKR1C1—Metabolism—PTEN—malignant glioma	2.97e-05	0.00032	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—MDM2—malignant glioma	2.95e-05	0.000318	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	2.95e-05	0.000318	CbGpPWpGaD
Salicylic acid—AKR1C1—Disease—MYC—malignant glioma	2.94e-05	0.000317	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—RAF1—malignant glioma	2.94e-05	0.000317	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—BCAN—malignant glioma	2.94e-05	0.000317	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—ASMT—malignant glioma	2.92e-05	0.000315	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—ERBB2—malignant glioma	2.91e-05	0.000314	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—JAG2—malignant glioma	2.88e-05	0.000311	CbGpPWpGaD
Salicylic acid—AKR1C1—Disease—EGFR—malignant glioma	2.88e-05	0.00031	CbGpPWpGaD
Salicylic acid—SLC16A1—Hemostasis—PIK3CA—malignant glioma	2.88e-05	0.00031	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—IDH1—malignant glioma	2.87e-05	0.00031	CbGpPWpGaD
Salicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	2.87e-05	0.00031	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—PIK3CB—malignant glioma	2.87e-05	0.000309	CbGpPWpGaD
Salicylic acid—ABCB1—Transmembrane transport of small molecules—SLC5A5—malignant glioma	2.87e-05	0.000309	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—PTK2—malignant glioma	2.86e-05	0.000309	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	2.85e-05	0.000308	CbGpPWpGaD
Salicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	2.85e-05	0.000307	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	2.84e-05	0.000307	CbGpPWpGaD
Salicylic acid—ALB—Platelet activation, signaling and aggregation—IL2—malignant glioma	2.84e-05	0.000306	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—malignant glioma	2.8e-05	0.000302	CbGpPWpGaD
Salicylic acid—SLC16A1—Hemostasis—TP53—malignant glioma	2.78e-05	0.0003	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—SPHK1—malignant glioma	2.78e-05	0.0003	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—GSTT1—malignant glioma	2.77e-05	0.000299	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—CXCL8—malignant glioma	2.76e-05	0.000297	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—BCAN—malignant glioma	2.74e-05	0.000296	CbGpPWpGaD
Salicylic acid—SLC16A1—Metabolism—CAV1—malignant glioma	2.74e-05	0.000296	CbGpPWpGaD
Salicylic acid—ABCB1—Transmembrane transport of small molecules—SLC6A3—malignant glioma	2.73e-05	0.000294	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—CYP2C18—malignant glioma	2.72e-05	0.000294	CbGpPWpGaD
Salicylic acid—AKR1C1—Disease—KRAS—malignant glioma	2.72e-05	0.000293	CbGpPWpGaD
Salicylic acid—SLC22A6—Transmembrane transport of small molecules—RAF1—malignant glioma	2.72e-05	0.000293	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—IDH2—malignant glioma	2.7e-05	0.000291	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—CASP3—malignant glioma	2.64e-05	0.000285	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—IL2—malignant glioma	2.63e-05	0.000284	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	2.63e-05	0.000283	CbGpPWpGaD
Salicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	2.62e-05	0.000282	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	2.59e-05	0.000279	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	2.57e-05	0.000277	CbGpPWpGaD
Salicylic acid—ALB—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	2.55e-05	0.000275	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—CYP2B6—malignant glioma	2.54e-05	0.000274	CbGpPWpGaD
Salicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	2.53e-05	0.000273	CbGpPWpGaD
Salicylic acid—AKR1C1—Disease—PIK3CA—malignant glioma	2.5e-05	0.000269	CbGpPWpGaD
Salicylic acid—SLC16A1—Metabolism—PIK3CG—malignant glioma	2.5e-05	0.000269	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—MMP9—malignant glioma	2.49e-05	0.000269	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—PTEN—malignant glioma	2.48e-05	0.000267	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—H3F3A—malignant glioma	2.44e-05	0.000263	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—BCHE—malignant glioma	2.42e-05	0.000261	CbGpPWpGaD
Salicylic acid—ALB—Platelet activation, signaling and aggregation—VEGFA—malignant glioma	2.41e-05	0.00026	CbGpPWpGaD
Salicylic acid—SLC16A1—Metabolism—PPARG—malignant glioma	2.41e-05	0.00026	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—PDGFB—malignant glioma	2.41e-05	0.00026	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—SLC5A5—malignant glioma	2.39e-05	0.000257	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	2.37e-05	0.000256	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—IDH2—malignant glioma	2.37e-05	0.000255	CbGpPWpGaD
Salicylic acid—SLC16A1—Hemostasis—AKT1—malignant glioma	2.35e-05	0.000253	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	2.34e-05	0.000252	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—IDH1—malignant glioma	2.32e-05	0.000251	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—JAG1—malignant glioma	2.3e-05	0.000248	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—CAV1—malignant glioma	2.28e-05	0.000246	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	2.26e-05	0.000243	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	2.26e-05	0.000243	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—FBXW7—malignant glioma	2.25e-05	0.000243	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—SPHK1—malignant glioma	2.25e-05	0.000242	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—VEGFA—malignant glioma	2.24e-05	0.000242	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	2.24e-05	0.000241	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—CYP2B6—malignant glioma	2.23e-05	0.00024	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—STAT3—malignant glioma	2.22e-05	0.000239	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—IDH2—malignant glioma	2.21e-05	0.000238	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—CYP2C18—malignant glioma	2.2e-05	0.000238	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—GSTT1—malignant glioma	2.2e-05	0.000237	CbGpPWpGaD
Salicylic acid—SLC16A1—Metabolism—PIK3CD—malignant glioma	2.19e-05	0.000237	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	2.18e-05	0.000236	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—FN1—malignant glioma	2.17e-05	0.000234	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—F2—malignant glioma	2.17e-05	0.000234	CbGpPWpGaD
Salicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	2.14e-05	0.00023	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	2.14e-05	0.00023	CbGpPWpGaD
Salicylic acid—AKR1C1—Metabolism—PIK3CA—malignant glioma	2.09e-05	0.000226	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	2.09e-05	0.000225	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—CYP2B6—malignant glioma	2.08e-05	0.000224	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—PIK3CG—malignant glioma	2.08e-05	0.000224	CbGpPWpGaD
Salicylic acid—ALB—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	2.08e-05	0.000224	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—PTGS1—malignant glioma	2.06e-05	0.000223	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—MYC—malignant glioma	2.06e-05	0.000222	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	2.06e-05	0.000222	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—EGF—malignant glioma	2.05e-05	0.000222	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—PTPN11—malignant glioma	2.04e-05	0.00022	CbGpPWpGaD
Salicylic acid—AKR1C1—Disease—AKT1—malignant glioma	2.04e-05	0.00022	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—IDH1—malignant glioma	2.04e-05	0.00022	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	2.03e-05	0.000219	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	2.02e-05	0.000218	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—EGFR—malignant glioma	2.02e-05	0.000217	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—SPHK1—malignant glioma	1.97e-05	0.000212	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.95e-05	0.00021	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—CYP2C18—malignant glioma	1.93e-05	0.000208	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—GSTP1—malignant glioma	1.92e-05	0.000207	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—BCHE—malignant glioma	1.92e-05	0.000207	CbGpPWpGaD
Salicylic acid—SLC16A1—Metabolism—PIK3CB—malignant glioma	1.91e-05	0.000206	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—KRAS—malignant glioma	1.9e-05	0.000205	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—IDH1—malignant glioma	1.9e-05	0.000205	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—AKT2—malignant glioma	1.9e-05	0.000205	CbGpPWpGaD
Salicylic acid—SLC16A1—Metabolism—PTGS2—malignant glioma	1.9e-05	0.000204	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—SLC5A5—malignant glioma	1.89e-05	0.000204	CbGpPWpGaD
Salicylic acid—ALB—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	1.89e-05	0.000204	CbGpPWpGaD
Salicylic acid—ALB—Platelet activation, signaling and aggregation—PIK3CA—malignant glioma	1.88e-05	0.000203	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—CAT—malignant glioma	1.87e-05	0.000202	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	1.85e-05	0.0002	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—SPHK1—malignant glioma	1.84e-05	0.000198	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—PIK3CD—malignant glioma	1.83e-05	0.000197	CbGpPWpGaD
Salicylic acid—ALB—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	1.83e-05	0.000197	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—CYP2C18—malignant glioma	1.8e-05	0.000194	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	1.79e-05	0.000193	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.79e-05	0.000193	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—GSTT1—malignant glioma	1.78e-05	0.000192	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—NCOR1—malignant glioma	1.77e-05	0.000191	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—CDKN2B—malignant glioma	1.77e-05	0.00019	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—PIK3CA—malignant glioma	1.75e-05	0.000189	CbGpPWpGaD
Salicylic acid—AKR1C1—Metabolism—AKT1—malignant glioma	1.71e-05	0.000184	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	1.7e-05	0.000183	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—TP53—malignant glioma	1.69e-05	0.000183	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—HES1—malignant glioma	1.68e-05	0.000182	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—NCOR1—malignant glioma	1.67e-05	0.000181	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—PTGS1—malignant glioma	1.67e-05	0.00018	CbGpPWpGaD
Salicylic acid—ALB—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1.66e-05	0.000179	CbGpPWpGaD
Salicylic acid—SLC16A1—Metabolism—PTEN—malignant glioma	1.65e-05	0.000178	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—RAF1—malignant glioma	1.63e-05	0.000176	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—PDGFRA—malignant glioma	1.6e-05	0.000173	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—PIK3CB—malignant glioma	1.59e-05	0.000172	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—GSTT1—malignant glioma	1.56e-05	0.000168	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—BCHE—malignant glioma	1.55e-05	0.000167	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	1.55e-05	0.000167	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.55e-05	0.000167	CbGpPWpGaD
Salicylic acid—ALB—Platelet activation, signaling and aggregation—AKT1—malignant glioma	1.54e-05	0.000166	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—SLC5A5—malignant glioma	1.53e-05	0.000165	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—GSTP1—malignant glioma	1.53e-05	0.000165	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	1.51e-05	0.000163	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	1.49e-05	0.000161	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—CAT—malignant glioma	1.48e-05	0.00016	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—TERT—malignant glioma	1.48e-05	0.000159	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—HLA-A—malignant glioma	1.48e-05	0.000159	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—PTGS1—malignant glioma	1.46e-05	0.000158	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—IL2—malignant glioma	1.46e-05	0.000158	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—GSTT1—malignant glioma	1.46e-05	0.000157	CbGpPWpGaD
Salicylic acid—ALB—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.45e-05	0.000156	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—PDGFB—malignant glioma	1.44e-05	0.000155	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—CAV1—malignant glioma	1.44e-05	0.000155	CbGpPWpGaD
Salicylic acid—ALB—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.44e-05	0.000155	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—FGFR1—malignant glioma	1.43e-05	0.000155	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—AKT1—malignant glioma	1.43e-05	0.000154	CbGpPWpGaD
Salicylic acid—ALB—Transmembrane transport of small molecules—RAF1—malignant glioma	1.41e-05	0.000152	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—HIF1A—malignant glioma	1.41e-05	0.000152	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—NCOR1—malignant glioma	1.4e-05	0.000151	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.38e-05	0.000148	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—PTGS1—malignant glioma	1.37e-05	0.000147	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—CAV1—malignant glioma	1.36e-05	0.000147	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1.36e-05	0.000147	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—BCHE—malignant glioma	1.36e-05	0.000147	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—SLC5A5—malignant glioma	1.34e-05	0.000145	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—PIK3CG—malignant glioma	1.31e-05	0.000141	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—BAD—malignant glioma	1.28e-05	0.000138	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—NOTCH1—malignant glioma	1.27e-05	0.000137	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—BCHE—malignant glioma	1.27e-05	0.000137	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—PPARG—malignant glioma	1.27e-05	0.000137	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—SLC5A5—malignant glioma	1.25e-05	0.000135	CbGpPWpGaD
Salicylic acid—ALB—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.25e-05	0.000135	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—CD80—malignant glioma	1.25e-05	0.000134	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—APC—malignant glioma	1.24e-05	0.000134	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—VEGFA—malignant glioma	1.24e-05	0.000134	CbGpPWpGaD
Salicylic acid—ABCB1—Transmembrane transport of small molecules—RAF1—malignant glioma	1.24e-05	0.000133	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—GSTP1—malignant glioma	1.23e-05	0.000133	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—EGF—malignant glioma	1.23e-05	0.000133	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—PTPN11—malignant glioma	1.22e-05	0.000132	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—CAT—malignant glioma	1.2e-05	0.00013	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.19e-05	0.000128	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.18e-05	0.000127	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—BRAF—malignant glioma	1.17e-05	0.000126	CbGpPWpGaD
Salicylic acid—SLC16A1—Metabolism—PIK3CA—malignant glioma	1.17e-05	0.000126	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—PIK3CD—malignant glioma	1.15e-05	0.000124	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—CAV1—malignant glioma	1.14e-05	0.000123	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—AKT2—malignant glioma	1.14e-05	0.000123	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—NCOR1—malignant glioma	1.13e-05	0.000122	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—PIK3CD—malignant glioma	1.09e-05	0.000118	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.09e-05	0.000118	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—GSTP1—malignant glioma	1.08e-05	0.000117	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—KRAS—malignant glioma	1.06e-05	0.000114	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—CAT—malignant glioma	1.05e-05	0.000114	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—FGF2—malignant glioma	1.05e-05	0.000113	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—PIK3CG—malignant glioma	1.04e-05	0.000112	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.03e-05	0.000111	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—GSTP1—malignant glioma	1.01e-05	0.000109	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—PIK3CB—malignant glioma	1.01e-05	0.000108	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—PPARG—malignant glioma	1e-05	0.000108	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—PTGS2—malignant glioma	9.96e-06	0.000107	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—NCOR1—malignant glioma	9.94e-06	0.000107	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—CAT—malignant glioma	9.83e-06	0.000106	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—MDM2—malignant glioma	9.79e-06	0.000106	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—RAF1—malignant glioma	9.76e-06	0.000105	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—PIK3CA—malignant glioma	9.71e-06	0.000105	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—ERBB2—malignant glioma	9.65e-06	0.000104	CbGpPWpGaD
Salicylic acid—SLC16A1—Metabolism—AKT1—malignant glioma	9.53e-06	0.000103	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—PIK3CB—malignant glioma	9.53e-06	0.000103	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—TP53—malignant glioma	9.39e-06	0.000101	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—NCOR1—malignant glioma	9.29e-06	0.0001	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—CAV1—malignant glioma	9.25e-06	9.97e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—PIK3CD—malignant glioma	9.15e-06	9.87e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	8.84e-06	9.53e-05	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—PTEN—malignant glioma	8.68e-06	9.37e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—PIK3CG—malignant glioma	8.42e-06	9.09e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—PTEN—malignant glioma	8.23e-06	8.88e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—PPARG—malignant glioma	8.13e-06	8.77e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—CAV1—malignant glioma	8.1e-06	8.74e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—PIK3CB—malignant glioma	7.98e-06	8.61e-05	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—AKT1—malignant glioma	7.93e-06	8.55e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—CAV1—malignant glioma	7.57e-06	8.16e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—PIK3CD—malignant glioma	7.41e-06	7.99e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—PIK3CG—malignant glioma	7.38e-06	7.96e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—STAT3—malignant glioma	7.36e-06	7.94e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	7.23e-06	7.8e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—PPARG—malignant glioma	7.12e-06	7.68e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—PIK3CG—malignant glioma	6.9e-06	7.44e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—PTEN—malignant glioma	6.89e-06	7.44e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—MYC—malignant glioma	6.84e-06	7.38e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—EGFR—malignant glioma	6.69e-06	7.22e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—PPARG—malignant glioma	6.65e-06	7.18e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—PIK3CD—malignant glioma	6.49e-06	7e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—PIK3CB—malignant glioma	6.45e-06	6.96e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—PTGS2—malignant glioma	6.4e-06	6.9e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—KRAS—malignant glioma	6.32e-06	6.82e-05	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—PIK3CA—malignant glioma	6.13e-06	6.61e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—PIK3CD—malignant glioma	6.06e-06	6.54e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—PIK3CA—malignant glioma	5.81e-06	6.26e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—PIK3CB—malignant glioma	5.66e-06	6.1e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—PTGS2—malignant glioma	5.6e-06	6.04e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—PTEN—malignant glioma	5.58e-06	6.02e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—PIK3CB—malignant glioma	5.28e-06	5.7e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—PTGS2—malignant glioma	5.24e-06	5.65e-05	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—AKT1—malignant glioma	5e-06	5.4e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—PTEN—malignant glioma	4.89e-06	5.27e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—PIK3CA—malignant glioma	4.86e-06	5.25e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—AKT1—malignant glioma	4.74e-06	5.12e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—PTEN—malignant glioma	4.57e-06	4.92e-05	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—AKT1—malignant glioma	3.97e-06	4.29e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—PIK3CA—malignant glioma	3.93e-06	4.24e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—PIK3CA—malignant glioma	3.45e-06	3.72e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—PIK3CA—malignant glioma	3.22e-06	3.47e-05	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—AKT1—malignant glioma	3.21e-06	3.47e-05	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—AKT1—malignant glioma	2.82e-06	3.04e-05	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—AKT1—malignant glioma	2.63e-06	2.84e-05	CbGpPWpGaD
